glp 1 drugs ro Guide to Oral GLP-1 Medications for Weight Loss and Diabetes It’s a pen. It’s a

Description

Limitations In this paper, our methodology was systematic in nature (Supplementary Section 1) as we sought to maximize the comprehensiveness of our search while providing a balanced overview of available literature

In atherosclerotic plaque models, semaglutide reduced macrophage infiltration and suppressed the M1 inflammatory program

p = 0.002

I would be very interested on your take on two things1) the very high discontinuation rate of these drugs (and the corresponding need for a focus on behavior change as an adjuvant/parallel to course of treatment) and, 2) the impact of significant lean muscle and bone loss during treatment w/GLP-1s